V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20060783 | 20086807 | 1.85 | 63.36 | null | 2019-01-29 | 2019-02-04 | Docetaxel | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100120443 |
| 20060818 | 20086808 | 1.67 | 57 | Adjuvant (A) | 2019-09-20 | 2019-09-24 | ARISTOTLE TRIAL | N | N | CHLORAMBUCIL + OBINUTUZUMAB | 101304588 |
| 20060835 | 20086809 | 0 | 36.2 | Adjuvant (A) | 2018-10-20 | 2018-10-20 | MCX | 02 | N | HYDROXYCARBAMIDE | 101397620 |
| 20060868 | 20086810 | 1.78 | 100 | Adjuvant (A) | 2019-06-13 | 2019-06-17 | Rituximab | N | N | CISPLATIN + FLUOROURACIL + RT | 101005077 |
| 20060968 | 20086811 | 1.71 | 66.8 | Adjuvant (A) | 2019-06-22 | 2019-06-22 | Bortezomib (weekly) | 02 | N | HYDROXYCARBAMIDE | 100512434 |
| 20060990 | 20086812 | 1.77 | 83.4 | 03 | 2016-06-09 | 2016-06-30 | CHOP R - 21 days | Y | N | EVEROLIMUS | 100018751 |
| 20061008 | 20086813 | 1.84 | 69.6 | 03 | 2017-07-11 | 2017-07-15 | PEMBROLIZUMAB | 02 | N | GO2 TRIAL | 101425701 |
| 20061037 | 20086814 | 1.8 | 67.4 | 03 | 2018-01-06 | 2018-01-15 | Cisplatin + Fluorouracil + Streptozocin | 02 | N | MITOMYCIN | 100299055 |
| 20061049 | 20086815 | 1.7 | 79.2 | 03 | 2016-03-16 | 2016-03-27 | OXALIPLATIN | 01 | Y | PACLITAXEL | 101611059 |
| 20061064 | 20086816 | 1.73 | 96 | null | 2016-08-09 | 2016-08-30 | Gemcitabine + Paclitaxel | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100872030 |
| 20061227 | 20086818 | 1.6 | 45.6 | Palliative (P) | 2017-05-27 | 2017-05-27 | CISPLATIN + FLUOROURACIL + RT | 02 | N | EOF | 101468861 |
| 20061281 | 20086819 | 1.62 | 58 | Palliative (P) | 2018-01-15 | 2018-01-27 | LENALIDOMIDE | 02 | N | CHOP | 100906161 |
| 20061399 | 20086821 | 1.74 | 72.7 | Palliative (P) | 2020-01-27 | 2020-02-05 | PEMBROLIZUMAB | 02 | N | ABIRATERONE | 101698301 |
| 20061525 | 20086824 | 1.62 | 62.4 | 03 | 2018-03-10 | 2018-03-10 | EEF or EOF | N | Y | ACELARATE TRIAL | 100048613 |
| 20061530 | 20086825 | 1.75 | 62 | Palliative (P) | 2018-11-01 | 2018-11-12 | COSMIC TRIAL | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101449398 |
| 20061546 | 20086826 | 1.65 | 89 | Palliative (P) | 2017-09-09 | 2017-09-14 | ECarboF | 02 | N | EVEROLIMUS | 101315053 |
| 20061586 | 20086827 | 1.76 | 70.8 | Palliative (P) | null | 2021-05-24 | Pazopanib | 02 | N | GO2 TRIAL | 100596696 |
| 20061606 | 20086828 | 1.63 | 7.1 | 03 | 2018-09-10 | 2018-09-10 | CAPECITABINE + CARBOPLATIN + Trastuzumab | null | N | DOCETAXEL | 101371613 |
| 20061625 | 20086829 | 1.66 | 85 | null | null | 2019-12-26 | EEF or EOF | 2 | N | ATEZOLIZUMAB | 100769388 |
| 20061641 | 20086830 | 1.66 | 88.85 | null | 2018-12-20 | 2019-01-06 | Hydroxycarbamide | Y | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101637334 |
| 20061825 | 20086832 | 1.68 | null | null | 2019-10-01 | 2019-10-13 | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 02 | N | CAP + RT | 101731093 |
| 20061955 | 20086833 | 1.74 | 88.6 | Palliative (P) | 2020-12-08 | 2020-12-08 | SCOPE 2 TRIAL | 02 | N | CISPLATIN + RT | 101504832 |
| 20062103 | 20086834 | 1.79 | 101.8 | Palliative (P) | 2018-11-11 | 2018-11-13 | PEMBROLIZUMAB | 02 | N | GO2 TRIAL | 101829191 |
| 20062129 | 20086835 | 1.57 | 62.8 | Adjuvant (A) | 2021-06-22 | 2021-07-19 | ANAGRELIDE | 02 | N | MITOMYCIN | 100436061 |
| 20062270 | 20086836 | 1.68 | 81 | Palliative (P) | 2016-09-03 | 2016-09-24 | Fluorouracil + Folinic + RT Bossett | 02 | N | SUNITINIB | 100322903 |
| 20062287 | 20086837 | 1.65 | 66.7 | 03 | 2018-05-21 | 2018-05-23 | Gemcitabine + Oxaliplatin | 02 | N | FLUOROURACIL + RT | 100939247 |
| 20062302 | 20086838 | 1.74 | 72.7 | null | 2016-11-18 | 2016-11-21 | MIC | 02 | N | PACLITAXEL | 101412143 |
| 20062332 | 20086839 | 1.63 | 50.4 | null | 2022-04-15 | 2022-04-21 | NIVOLUMAB | 02 | N | UKALL2014 | 100678347 |
| 20062389 | 20086840 | 1.69 | 75.5 | Palliative (P) | 2019-12-05 | 2019-12-15 | Hydroxycarbamide | 02 | N | MITOMYCIN | 100414109 |
| 20062395 | 20086841 | 1.5 | 48.9 | 03 | 2017-12-16 | 2017-12-18 | Docetaxel 75mg/m2 (21 day) | 02 | N | TEMOZOLOMIDE | 100680052 |
| 20062431 | 20086842 | 1.82 | 42.5 | Palliative (P) | 2016-12-23 | 2016-12-28 | OXALIPLATIN | N | N | CARBO + FLUOROURACIL | 100818494 |
| 20062498 | 20086843 | 1.68 | 71.5 | Adjuvant (A) | 2019-12-31 | 2020-01-15 | Irinotecan 14day | 2 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100273572 |
| 20062499 | 20086844 | 1.61 | 53.6 | 03 | 2018-11-06 | 2018-11-07 | EVEROLIMUS | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100007401 |
| 20062544 | 20086845 | 1.63 | 140.2 | Palliative (P) | 2018-01-30 | 2018-02-10 | CISPLATIN + FLUOROURACIL + RT | 02 | N | PLATO TRIAL | 101467938 |
| 20062545 | 20086846 | 1.58 | 59.8 | Adjuvant (A) | 2019-07-14 | 2019-07-14 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | NAB-PACLITAXEL | 101244466 |
| 20062548 | 20086847 | 1.66 | 84.4 | Palliative (P) | 2016-09-05 | 2016-09-15 | ECarboX | 02 | N | PACLITAXEL | 101677321 |
| 20062575 | 20086848 | 1.73 | 97.4 | Adjuvant (A) | 2018-09-24 | 2018-10-19 | Cisplatin + Pemetrexed | N | N | PACLITAXEL | 101348017 |
| 20062614 | 20086849 | 1.69 | 102.7 | Palliative (P) | 2021-12-04 | 2021-12-18 | Carboplatin + Liposomal Doxorubicin | 02 | N | AZACITIDINE | 101647803 |
| 20062699 | 20086850 | null | null | null | 2015-09-25 | 2015-09-28 | Lenalidomide 15mg (Cycle 1 to 25) | 02 | Y | DOCETAXEL | 100428795 |
| 20062811 | 20086851 | 1.78 | 103 | 03 | 2018-02-25 | 2018-03-02 | FCarboSt | 02 | N | CAPECITABINE + STREPTOZOCIN | 100709845 |
| 20062872 | 20086852 | 1.62 | 68.6 | null | 2021-09-27 | 2021-10-12 | Pazopanib | 02 | N | ACTICCA-1 TRIAL | 101403551 |
| 20062881 | 20086853 | 1.7 | 74.8 | Palliative (P) | 2017-08-29 | 2017-08-29 | CISPLATIN + TEYSUNO | 02 | Y | RITUXIMAB | 101635047 |
| 20062931 | 20086854 | 1.55 | 86.25 | 03 | 2021-06-25 | 2021-07-08 | NIVOLUMAB | N | N | PEMBROLIZUMAB | 101010903 |
| 20063004 | 20086855 | 1.7 | 73.8 | Palliative (P) | 2017-11-01 | 2017-11-04 | EOF | 02 | null | MCX | 100210985 |
| 20063021 | 20086856 | 1.69 | 97.1 | 03 | 2018-01-02 | 2018-01-30 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | ERIBULIN | 100357790 |
| 20063028 | 20086857 | 1.8 | 105 | null | null | 2017-10-09 | null | 02 | N | ARISTOTLE TRIAL | 100128107 |
| 20063084 | 20086858 | null | null | 03 | 2018-05-26 | 2018-05-27 | EVEROLIMUS | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100971181 |
| 20063104 | 20086859 | 1.76 | 48.5 | Palliative (P) | 2016-02-24 | 2016-03-06 | CISPLATIN + TEYSUNO | 01 | N | ARISTOTLE TRIAL | 100048435 |
| 20063158 | 20086860 | 1.81 | 107 | Adjuvant (A) | 2018-03-31 | 2018-04-16 | null | 02 | N | SUNITINIB | 100834000 |
| 20063172 | 20086861 | 1.56 | 78.25 | Palliative (P) | 2017-10-11 | 2017-11-07 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 99 | N | TCX | 101790787 |